story • 1 min read Organigram Reports Its 10870277 Canada Subsidiary Purchased 25% (~8.3K Common Shares) Of alpha-cannabis Pharma For Proceeds Of €1.625M igniteit October 17, 2018 • 11:53 am Share:
